Bulk RNA-seq analysis of sorted tumour-infiltrating CD8+ T cells revealed higher expression of IFNG, GZMB and PRF1 in post-treatment samples, indicating enhanced cytotoxic potential of tumour-infiltrating CD8+ T cells following PI3Kδi treatment (Fig. 1d). The gene discussed is CD8A; the disease is neoplasm.